Steven M Graves
Overview
Explore the profile of Steven M Graves including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
1070
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ewens A, Pilski A, Hastings S, Krook-Magnuson C, Graves S, Krook-Magnuson E, et al.
J Pharmacol Exp Ther
. 2024 Jul;
391(1):104-118.
PMID: 39060163
Human immunodeficiency virus (HIV)-associated neurocognitive disorder (HAND) affects nearly half of the 39 million people living with HIV. HAND symptoms range from subclinical cognitive impairment to dementia; the mechanisms that...
2.
Plotkin J, Graves S, Riessland M
Front Cell Neurosci
. 2024 Mar;
18:1385783.
PMID: 38486711
No abstract available.
3.
Spear S, Salcedo P, Graves S, Xie H
J Subst Use Addict Treat
. 2023 Dec;
159:209256.
PMID: 38072382
Introduction: Little attention has been paid to the built environment of outpatient opioid treatment programs, despite the need to increase access to medications for opioid use disorder, particularly among people...
4.
Pilski A, Graves S
Int J Mol Sci
. 2023 Sep;
24(17).
PMID: 37685846
Methamphetamine (meth) is a neurotoxic psychostimulant that increases monoamine oxidase (MAO)-dependent mitochondrial oxidant stress in axonal but not somatic compartments of substantia nigra pars compacta (SNc) and locus coeruleus (LC)...
5.
Choi S, Methiwala H, Graves S
Brain Res
. 2023 Aug;
1818:148528.
PMID: 37567548
Methamphetamine (meth) is an addictive psychostimulant and there are no FDA-approved treatment options for patients suffering from meth use disorders. In addition to being addictive, meth is also neurotoxic and...
6.
Du Y, Choi S, Pilski A, Graves S
Front Cell Neurosci
. 2022 Aug;
16:949923.
PMID: 35936499
Methamphetamine (meth) increases monoamine oxidase (MAO)-dependent mitochondrial stress in axons of substantia nigra pars compacta (SNc), and ventral tegmental area (VTA) dopamine neurons. Chronic administration of meth results in SNc...
7.
Choi S, Du Y, Wokosin D, Graves S
Sci Rep
. 2022 Jul;
12(1):12116.
PMID: 35840639
Methamphetamine (meth) is an addictive psychostimulant and illicit use presents significant personal and socioeconomic harm. Behavioral studies support the involvement of the dorsal striatum in drug-seeking but stimulant induced dysfunction...
8.
Voda M, Murgu A, Sarpe C, Graves S, Avram C
Int J Environ Res Public Health
. 2021 Oct;
18(20).
PMID: 34682367
Romanian rural villages are struggling to survive present times when youngsters leave for a better life in the city while elders work the land like a hundred years ago. Our...
9.
Du Y, Lee Y, Graves S
Neuropharmacology
. 2021 Oct;
200:108817.
PMID: 34610287
Methamphetamine (meth) increases monoamine oxidase (MAO)-dependent mitochondrial stress in substantia nigra pars compacta (SNc) axons; chronic administration produces SNc degeneration that is prevented by MAO inhibition suggesting that MAO-dependent axonal...
10.
Persons A, Bradaric B, Kelly L, Kousik S, Graves S, Yamamoto B, et al.
Drug Alcohol Depend
. 2021 Jun;
225:108746.
PMID: 34098381
Introduction: Methamphetamine is a potent psychomotor stimulant, and methamphetamine abusers are up to three times more likely to develop Parkinson's disease (PD) later in life. Prodromal PD may involve gut...